Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2747780

CCCCCCCCCCCCCC(C)(C)NCCC[Si](OC)(OC)OC.Cl

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
EPHX1 P07099 2/20 0.33
KDM4E B2RXH2 1/20 0.30
TP53 P04637 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPT P10636 1/20 0.30
ALOX15 P16050 1/20 0.30
TSHR P16473 1/20 0.30
ACAT1 P24752 1/20 0.30
SOAT1 P35610 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL895838 1.00 LMNA (0.44) LMNAEPHX1KDM4ETP53CYP3A4
Hydrochloric Acid SCHEMBL6559392 1.00 LMNA (0.44) LMNAEPHX1KDM4ETP53CYP3A4
SCHEMBL1123152 0.98 LMNA (0.45) LMNAEPHX1KDM4ETP53CYP3A4
SCHEMBL2135346 0.98 LMNA (0.45) LMNAEPHX1KDM4ETP53CYP3A4
SCHEMBL27124590 0.98 LMNA (0.45) LMNAEPHX1KDM4ETP53CYP3A4
SCHEMBL1123281 0.98 LMNA (0.45) LMNAEPHX1KDM4ETP53CYP3A4
Bromide SCHEMBL15564400 0.97 LMNA (0.44) LMNAEPHX1KDM4ETP53CYP3A4
Bromide SCHEMBL16931586 0.97 LMNA (0.44) LMNAEPHX1KDM4ETP53CYP3A4
SCHEMBL1123424 0.90 LMNA (0.39) LMNA
Hydrochloric Acid SCHEMBL352060 0.89 LMNA (0.41) LMNAEPHX1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066620-A1 WATER-BORNE HYBRID VARNISH AND THE METHOD OF ITS PREPARATION Vysoké ucení technické v Brne 2025-02-27 US claimed
EP-4103635-B1 POLYURETHANE FOAM COMPOSITIONS WITH ANTIMICROBIAL PROPERTIES SANITIZED AG (CH) 2025-01-08 EP claimed
WO-2023116955-A1 WATER-BORNE HYBRID VARNISH AND THE METHOD OF ITS PREPARATION Centrum organické chemie s.r.o. (CZ) 2023-06-29 WO claimed
US-20230128969-A1 POLYURETHANE FOAM COMPOSITIONS WITH ANTIMICROBIAL PROPERTIES SANITIZED AG (CH) 2023-04-27 US claimed
EP-4103635-A1 POLYURETHANE FOAM COMPOSITIONS WITH ANTIMICROBIAL PROPERTIES Sanitized AG (CH) 2022-12-21 EP claimed
WO-2021160757-A1 POLYURETHANE FOAM COMPOSITIONS WITH ANTIMICROBIAL PROPERTIES SANITIZED AG (CH) 2021-08-19 WO claimed
US-9204633-B2 Using an unsubstituted quatenary ammonium salt composition with other ingredients as a skin sanitizing solution and natural skin conditioner APHEX BIOCLEANSE SYSTEMS, INC. (US) 2015-12-08 US claimed
US-20150045443-A1 USING AN UNSUBSTITUTED QUATENARY AMMONIUM SALT COMPOSITION WITH OTHER INGREDIENTS AS A SKIN SANITIZING SOLUTION AND NATURAL SKIN CONDITIONER APHEX BIOCLEANSE SYSTEMS, INC (US) 2015-02-12 US claimed
US-8178119-B2 Zinc pyrithione, triclosan, polymeric binder, fluorocarbon hydrophobicizing agent; against colonization by house dust mites; mattress ticking, furniture covering fabrics and carpets SANITIZED AG (CH) 2012-05-15 US claimed
US-20080260860-A1 Method for the Acaricidal Finishing of Textile Materials SANITIZED AG (CH) 2008-10-23 US claimed
US-20250359547-A1 ALKOXYLATED ALKANOLS FOR ENHANCING THE ACTIVITY OF ANTIMICROBIAL AGENTS BASF SE (DE) 2025-11-27 US disclosed
US-20250176548-A1 POLYMERIC IMIDAZOLIUM COMPOUNDS FOR ENHANCING THE ACTIVITY OF ANTIMICROBIAL AGENTS BASF SE (DE) 2025-06-05 US disclosed
EP-4103635-B1 POLYURETHANE FOAM COMPOSITIONS WITH ANTIMICROBIAL PROPERTIES SANITIZED AG (CH) 2025-01-08 EP disclosed
EP-3778160-B1 RESIN COMPOSITION, RESIN COATING, LAMINATES CONTAINING SAME AND IMPREGNATES CONTAINING THE SAME AND METHOD FOR PRODUCING THE SAME FRITZ EGGER GMBH & CO OG (AT) 2024-06-19 EP disclosed
WO-2023190318-A1 FILTER MEDIUM 東レ株式会社 2023-10-05 WO disclosed
EP-2880102-A1 PARTICULATE METAL OXIDE PARTICLES COMPRISING A METAL OXIDE CORE AND A COATING LAYER COMPRISING AN INORGANIC MATERIAL, A SILANE COUPLING AGENT AND/OR A HYDROPHOBIZING AGENT Croda International PLC (GB) 2015-06-10 EP disclosed
US-20140308330-A1 CORE-SHELL QUATERNARY AMMONIUM NANOMATERIALS, METHODS AND APPLICATIONS UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2014-10-16 US disclosed
WO-2014023932-A1 PARTICULATE METAL OXIDE PARTICLES COMPRISING A METAL OXIDE CORE AND A COATING LAYER COMPRISING AN INORGANIC MATERIAL, A SILANE COUPLING AGENT AND/OR A HYDROPHOBIZING AGENT CRODA INTERNATIONAL PLC (GB) 2014-02-13 WO disclosed
US-8178119-B2 Zinc pyrithione, triclosan, polymeric binder, fluorocarbon hydrophobicizing agent; against colonization by house dust mites; mattress ticking, furniture covering fabrics and carpets SANITIZED AG (CH) 2012-05-15 US disclosed
US-20080260860-A1 Method for the Acaricidal Finishing of Textile Materials SANITIZED AG (CH) 2008-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359547-A1 ALKOXYLATED ALKANOLS FOR ENHANCING THE ACTIVITY OF ANTIMICROBIAL AGENTS CAT, LPO, ALKBH1 LMNA 3826/4885EPHX1 729/4885KDM4E 2986/4885
US-20250176548-A1 POLYMERIC IMIDAZOLIUM COMPOUNDS FOR ENHANCING THE ACTIVITY OF ANTIMICROBIAL AGENTS MPO, MIF, ARG1 LMNA 4295/4885EPHX1 4569/4885KDM4E 3533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.